PHARMATHENE, INC·4

Dec 5, 8:22 PM ET

Karp Jordan P 4

4 · PHARMATHENE, INC · Filed Dec 5, 2011

Insider Transaction Report

Form 4
Period: 2011-12-01
Karp Jordan P
Senior VP, General Counsel
Transactions
  • Award

    Stock Options (right to buy)

    2011-12-01+75,00075,000 total
    Exercise: $1.21Exp: 2021-12-01Common Stock (75,000 underlying)
  • Award

    Stock Options (right to buy)

    2011-12-01+36,90036,900 total
    Exercise: $1.21Exp: 2021-12-01Common Stock (36,900 underlying)
Footnotes (3)
  • [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
  • [F2]On December 1, 2011, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.21 per share.
  • [F3]The options vest 100% on the first anniversary of the grant date.

Documents

1 file
  • 4
    v242399_4.xmlPrimary

    OWNERSHIP DOCUMENT